More work in a larger patient population is needed to dissect the role of FAP in various histopathologic variants and hormone-receptor status within the tumor microenvironment and explore its role as a potentially targetable molecule in breast cancer treatment. The gene discussed is NR4A1; the disease is breast cancer.